Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Atraumatic fractures caused by osteoporosis may be a serious complication of primary biliary cirrhosis. Mean (± S.D.) bone mineral density in the lumbar spine in 210 ambulatory women with primary biliary cirrhosis was 1.02 ± 0.19 gm/cm 2, 7% lower than that in 139 age-matched normal women (after adjustment for age and body weight) (p < 0.001). Bone mineral density in the lumbar spine was inversely related to a risk score index of liver disease severity (r = −0.29, p < 0.001). The mean rate of bone loss in 105 of these 210 women was 2%/yr ± 4%/yr, twice as great as in the 139 normal women (p < 0.02). In 20 women with primary biiary cirrhosis followed up after orthotopic liver transplantation, bone mineral density in the lumbar spine decreased at 3 mo (p < 0.01), and this decrease may have resulted in atraumatic fractures in 13 of them. Bone mineral density in the lumbar spine then increased (p < 0.01) so that by 12 mo the median bone mineral density in the lumbar spine was similar to that before transplantation and by 24 mo it was 5% above it. Therefore we conclude that the progressive bone loss observed in primary biliary cirrhosis (which is further accentuated immediately after transplantation) may be halted, and the bone mass may be restored toward normal within 2 to 3 yr after orthotopic liver transplantation. (HEPATOLOGY 1991;14:296-300.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Osteopenia may worsen for the first 6 months after transplantation, but bone mineral density returns to baseline after 12 months and improves thereafter.(254)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [254]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Applied Regression Analysis and Other Multivariable Methods.
Bhattacharyya, H. T., Kleinbaum, D. G., & Kupper, L. L. (1979) · Journal of the American Statistical Association · doi:10.2307/2287012 · Cited by 1,749
Riggs, B. L., Wahner, H. W., Dunn, W. L., Mazess, R. B., Offord, K. P., & Melton, L. J. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110039 · Cited by 1,194
Self-citationPrognosis in primary biliary cirrhosis: Model for decision making
Dickson, R. E., Grambsch, P. M., Fleming, T. R., Fisher, L. D., & Langworthy, A. (1989) · Hepatology · doi:10.1002/hep.1840100102 · Cited by 816
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)
Ludwig, J., Dickson, E. R., & McDonald, G. S. A. (1978) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00432479 · Cited by 753
Riggs, B. L., Wahner, H. W., Melton, L. J., Richelson, L. S., Judd, H. L., & Offord, K. P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112462 · Cited by 510
Self-citationAHRENS, E. H., PAYNE, M. A., KUNKEL, H. G., EISENMENGER, W. J., & BLONDHEIM, S. H. (1950) · Medicine · doi:10.1097/00005792-195012000-00002 · Cited by 436
MOVSOWITZ, C., EPSTEIN, S., FALLON, M., ISMAIL, F., & THOMAS, S. (1988) · Endocrinology · doi:10.1210/endo-123-5-2571 · Cited by 404
Clinical Disorders of Bone and Mineral Metabolism
FRAME, B., & MAREL, G. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-5-725 · Cited by 322
Research works printed but not linked: 5
- Cox, 1972, J R Stat Soc, Series B., 34, 248
- Atkinson, 1955, Q J Med, 99, 299
- Stellon, 1985, Q J Med, 57, 783
- Hodgson, 1987, Clin Res, 35, 861a
- Klaushofer, 1987, J Pharmacol Exp Ther, 243, 584
Cited by
(2011) · Encyclopedia of Cancer · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,240
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
“(253) Osteopenia may worsen for the first 6 months after transplantation, but bone mineral density returns to baseline after 12 months and improves thereafter.(254) Alendronate is a more effective treatment than etidronate,(255) but there are no studies to confirm the longterm efficacy of any treatment.”
BackgroundCarey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Management of primary biliary cirrhosis
Heathcote, J. E. (2000) · Hepatology · doi:10.1053/he.2000.5984 · Cited by 417
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
Eastell, R., Reid, D. M., Compston, J., Cooper, C., Fogelman, I., Francis, R. M., Hosking, D. J., Purdie, D. W., Ralston, S. H., Reeve, J., et al. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00408.x · Cited by 315
Self-citationSecondary Causes of Osteoporosis
FITZPATRICK, L. A. (2002) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62214-3 · Cited by 311
Talwalkar, J. A., & Lindor, K. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13808-1 · Cited by 290
Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton
Epstein, S. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110102 · Cited by 273
Leidig-Bruckner, G., Hosch, S., Dodidou, P., Ritschel, D., Conradt, C., Klose, C., Otto, G., Lange, R., Theilmann, L., Zimmerman, R., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03641-2 · Cited by 267
LONG-TERM MEDICAL COMPLICATIONS IN PATIENTS SURVIVING ???5 YEARS AFTER LIVER TRANSPLANT
Sheiner, P. A., Magliocca, J. F., Bodian, C. A., Kim-Schluger, L., Altaca, G., Guarrera, J. V., Emre, S., Fishbein, T. M., Guy, S. R., Schwartz, M. E., et al. (2000) · Transplantation · doi:10.1097/00007890-200003150-00018 · Cited by 262
Osteoporosis after Organ Transplantation
Rodino, M. A., & Shane, E. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00081-3 · Cited by 249
Increased Risk of Fracture in Patients Receiving Solid Organ Transplants
Ramsey-Goldman, R., Dunn, J. E., Dunlop, D. D., Stuart, F. P., Abecassis, M. M., Kaufman, D. B., Langman, C. B., Salinger, M. H., & Sprague, S. M. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.3.456 · Cited by 248
“(11–15) The lowest rates were in patients with chronic active hepatitis(12) and the highest were in patients with PBC.(15) Our study has several limitations.”
BackgroundInfluentialOsteoporosis in lung transplantation candidates with end-stage pulmonary disease
Shane, E., Silverberg, S. J., Donovan, D., Papadopoulos, A., Staron, R. B., Addesso, V., Jorgesen, B., McGregor, C., & Schulman, L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00155-6 · Cited by 243
Guidelines on the management of osteoporosis associated with chronic liver disease
Collier, J. D., Ninkovic, M., & Compston, J. E. (2002) · Gut · doi:10.1136/gut.50.suppl_1.i1 · Cited by 241
Bone disorders in chronic liver disease
Collier, J. (2007) · Hepatology · doi:10.1002/hep.21852 · Cited by 238
AGA technical review on osteoporosis in hepatic disorders
LESLIE, W. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01062-x · Cited by 232
Monegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., Martinez de Osaba, M. J., Rimola, A., Rodés, J., & Muñoz-Gómez, J. (1997) · Calcified Tissue International · doi:10.1007/s002239900205 · Cited by 210
Bone mineral density before and after OLT: Long-term follow-up and predictive factors
Guichelaar, M. M. J., Kendall, R., Malinchoc, M., & Hay, J. E. (2006) · Liver Transplantation · doi:10.1002/lt.20874 · Cited by 207
“Following OLT, however, this situation changes, as early aggressive bone loss occurs in almost all patients.(5-10) In patients who are already osteoporotic or osteopenic, this further bone loss results in an increase in fracture rates.”
BackgroundInfluentialJanes, C. H., Dickson, E. R., Okazaki, R., Bonde, S., McDonagh, A. F., & Riggs, B. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117959 · Cited by 195
Osteoporosis after solid organ and bone marrow transplantation
Cohen, A., & Shane, E. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1426-z · Cited by 193
“Recovery of BMD at the spine and hip has been documented during the second and third years following transplantation in patients receiving no treatment for bone disease [26,28,122,127,128].”
BackgroundInfluentialSarkar, M., Brady, C. W., Fleckenstein, J., Forde, K. A., Khungar, V., Molleston, J. P., Afshar, Y., & Terrault, N. A. (2021) · Hepatology · doi:10.1002/hep.31559 · Cited by 186
“(74,75) Patients with advanced liver disease have decreased bone synthesis; increased bone resorption, poor nutritional status, and reduced muscle mass and immobility further increase this risk.(76-80) Hormone replacement therapy is used in the management of menopausal symptoms and bone health.”
BackgroundOsteoporosis after cardiac transplantation
Shane, E., Rivas, M. D. C., Silverberg, S. J., Kim, T. S., Staron, R. B., & Bilezikian, J. P. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90057-v · Cited by 190
Bone loss after orthotopic liver transplantation
Meys, E., Fontanges, E., Fourcade, N., Thomasson, A., Pouyet, M., & Delmas, P. D. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90324-7 · Cited by 187
Monegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., Martinez de Osaba, M. J., Ordi, J., Rimola, A., Rodés, J., & Muñoz-Gómez, J. (2001) · Osteoporosis International · doi:10.1007/s001980170094 · Cited by 183
“Although the pathogenesis of post-transplantation bone loss is poorly understood, it is believed that pre-existing bone disease and immunosuppressive agents are important contributing factors [6,7,10,11].”
BackgroundOsteoporosis and bone morbidity in cardiac transplant recipients
Lee, A. H., Mull, R. L., Keenan, G. F., Callegari, P. E., Dalinka, M. K., Eisen, H. J., Mancini, D. M., DiSesa, V. J., & Attie, M. F. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90113-9 · Cited by 184
Bone disease in primary biliary cirrhosis: independent indicators and rate of progression
Menon, K. V. N., Angulo, P., Weston, S., Dickson, E. R., & Lindor, K. D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00144-1 · Cited by 180
Sacral insufficiency fractures: current concepts of management
Tsiridis, E. E., Upadhyay, N., & Giannoudis, P. V. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0175-1 · Cited by 189
“Several pathological entities superimposing or being the underlying cause of osteoporosis may be involved, including hyperparathyroidism [60], osteomalacia, renal osteodystrophy [40, 61], lumbosacral fusion [51], Paget’s disease [16, 33], reconstructive surgery of the lower limb [7, 35] and transplantation of lung, he…”
BackgroundFracture after cardiac transplantation: a prospective longitudinal study
Shane, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1740 · Cited by 155
Springer, J., Cole, D. E. C., Rubin, L. A., Cauch‐Dudek, K., Harewood, L., Evrovski, J., Peltekova, V. D., & Heathcote, E. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70423-9 · Cited by 157
Zein, C. O., Jorgensen, R. A., Clarke, B., Wenger, D. E., Keach, J. C., Angulo, P., & Lindor, K. D. (2005) · Hepatology · doi:10.1002/hep.20866 · Cited by 142
Calcitonin and bisphosphonates treatment in bone loss after liver transplantation
Valero, M. A., Loinaz, C., Larrodera, L., Leon, M. W. D., Moreno, E., & Hawkins, F. G. (1995) · Calcified Tissue International · doi:10.1007/bf00298990 · Cited by 137
“[1] concluded that the most likely explanation for the recovery in bone density is that bone mass is increased when initial high dose steroid is decreased.”
BackgroundOsteoporosis in chronic liver disease
Guañabens, N., & Parés, A. (2018) · Liver International · doi:10.1111/liv.13730 · Cited by 128
Carey, E. J., Balan, V., Kremers, W. K., & Hay, E. J. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50242 · Cited by 126
“Percent of patients treated with OKT3 2 (3) 3 (5) 5 (7) .”
Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?
Lindor, K. D., Janes, C. H., Crippin, J. S., Jorgensen, R. A., & Dickson, R. E. (1995) · Hepatology · doi:10.1002/hep.1840210219 · Cited by 127
Self-citationOsteoporosis and Lung Transplantation
Spira, A. E., Gutierrez, C., Chaparro, C., Hutcheon, M., & Chan, C. K. (2000) · CHEST Journal · doi:10.1378/chest.117.2.476 · Cited by 124
Ninkovic, M., Love, S. A., Tom, B., Alexander, G. J. M., & Compston, J. E. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-2028-4 · Cited by 123
BONE LOSS AND FRACTURE AFTER LUNG TRANSPLANTATION1
Shane, E., Papadopoulos, A., Staron, R. B., Addesso, V., Donovan, D., McGregor, C., & Schulman, L. L. (1999) · Transplantation · doi:10.1097/00007890-199907270-00010 · Cited by 124
Angulo, P., Therneau, T. M., Jorgensen, R. A., DeSotel, C. K., Egan, K. S., Dickson, E. R., Hay, J. E., Hay, J. E., & Lindor, K. D. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80253-5 · Cited by 120
Guañabens, N., Parés, A., Ros, I., Alvarez, L., Pons, F., Caballería, L., Monegal, A., de Osaba, J. M. M., Roca, M., Peris, P., et al. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07639.x · Cited by 119
The metabolic bone disease of primary sclerosing cholangitis
Hay, J. E. (1991) · Hepatology · doi:10.1016/0270-9139(91)91412-t · Cited by 119
Risk of fractures in patients with pernicious anemia
Goerss, J. B., Kim, C. H., Atkinson, E. J., Eastell, R., O'Fallon, W. M., & Dr. Melton, L. J. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070514 · Cited by 119
Self-citationOsteoporosis after liver transplantation
Compston, J. E. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50044 · Cited by 116
Wolfhagen, F. H. J., van Buuren, H. R., den Ouden, J. W., Hop, W. C. J., van Leeuwen, J. P. T. M., Schalm, S. W., & Pols, H. A. P. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80048-7 · Cited by 121
Bone disease in cholestatic liver disease
Hay, J. E. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90033-0 · Cited by 125
Disorders Associated With Acute Rapid and Severe Bone Loss
Epstein, S., Inzerillo, A. M., Caminis, J., & Zaidi, M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.12.2083 · Cited by 112
“Patients with primary biliary cirrhosis have a high, 65%, incidence of atraumatic fractures of the spine, hip, ribs, and long bones within the first year after transplantation.((101,102)) In general, the dosages of immunosuppressants used in liver transplant patients are higher than those used in renal and even cardia…”
BackgroundCirrhosis, W. S. (. V. F. C. P. G. F. P. B. (2014) · Hepatology Research · doi:10.1111/hepr.12270 · Cited by 124
Oursler, M. J. (1993) · Endocrinology · doi:10.1210/en.133.5.2187 · Cited by 111
High Prevalence of Celiac Sprue among Patients with Primary Biliary Cirrhosis
Dickey, W., McMillan, S. A., & Callender, M. E. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199707000-00006 · Cited by 110
Reeves, H. L., Francis, R. M., Manas, D. M., Hudson, M., & Day, C. P. (1998) · Liver Transplantation and Surgery · doi:10.1002/lt.500040508 · Cited by 108
Hodgson, S. F., Dickson, E. R., Eastell, R., Eriksen, E. F., Bryant, S., & Riggs, B. L. (1993) · Bone · doi:10.1016/8756-3282(93)90310-7 · Cited by 113
Self-citationPrimary biliary cirrhosis—presentation and diagnosis
Leuschner, U. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00101-6 · Cited by 106
Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications
Nakchbandi, I. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9427 · Cited by 105
Osteoporosis in primary biliary cirrhosis revisited
Newton, J., Francis, R., Prince, M., James, O., Bassendine, M., Rawlings, D., & Jones, D. (2001) · Gut · doi:10.1136/gut.49.2.282 · Cited by 100
Bone mineral density among cirrhotic patients awaiting liver transplantation
Sokhi, R. P., Anantharaju, A., Kondaveeti, R., Creech, S. D., Islam, K. K., & Van Thiel, D. H. (2004) · Liver Transplantation · doi:10.1002/lt.20104 · Cited by 96
Ninkovic, M., Love, S., Tom, B. D. M., Bearcroft, P. W. P., Alexander, G., & Compston, J. E. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00100-9 · Cited by 96
Secondary osteoporosis: Underlying disease and the risk for glucocorticoid-induced osteoporosis
Boling, E. P. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90001-x · Cited by 98
Millonig, G., Graziadei, I. W., Eichler, D., Pfeiffer, K.-P., Finkenstedt, G., Muehllechner, P., Koenigsrainer, A., Margreiter, R., & Vogel, W. (2005) · Liver Transplantation · doi:10.1002/lt.20466 · Cited by 87
Isoniemi, H., Appelberg, J., Nilsson, C.-G., Mäkelä, P., Risteli, J., & Höckerstedt, K. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00067-2 · Cited by 84
Bone density and turnover in Addison's disease: effect of glucocorticoid treatment
Valero, M. A., Leon, M. W. D., Valdepeñas, M. P. R., Larrodera, L., López, M., Papapietro, K., Jara, A., & Hawkins, F. G. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80158-4 · Cited by 82
Högler, W., Baumann, U., & Kelly, D. A. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31823e9412 · Cited by 85
Long-Term Persistence of Low Bone Density in Orthotopic Liver Transplantation
Giannini, S., Nobile, M., Ciuffreda, M., Iemmolo, R. M., Dalle Carbonare, L., Minicuci, N., Casagrande, F., Destro, C., Gerunda, G. E., Sartori, L., et al. (2000) · Osteoporosis International · doi:10.1007/s001980070109 · Cited by 77
“hepatic function and the resolution of cholestasis after surgery [2, 5 ].”
BackgroundResultInfluentialPrimary biliary cirrhosis and osteoporosis: a case-control study
Mounach, A., Ouzzif, Z., Wariaghli, G., Achemlal, L., Benbaghdadi, I., Aouragh, A., Bezza, A., & Maghraoui, A. E. (2008) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-007-0833-1 · Cited by 84
“It has been suggested that untreated women with PBC lose bone mass at a rate approximately twice that seen in age-matched controls [1].”
BackgroundEtidronate for osteoporosis in primary biliary cirrhosis: a randomized trial
Lindor, K. D., Jorgensen, R. A., Tiegs, R. D., Khosla, S., & Dickson, E. R. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80118-x · Cited by 79
Mechanism of bone loss after liver transplantation: A histomorphometric analysis
Vedi, S., Greer, S., Skingle, S. J., Garrahan, N. J., Ninkovic, M., Alexander, G. A., & Dr. Compston, J. E. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.2.281 · Cited by 74
Trautwein, C. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)01061-3 · Cited by 73
“(7), and, apart from the decreased activity of osteoblasts (8–10), there are also studies indicating an increase in osteoclast activity (11, 12).”
BackgroundParenteral Calcitonin for Metabolic Bone Disease Associated With Primary Biliary Cirrhosis
Crosignani, A., Battezzati, P. M., Albisetti, W., Grandinetti, G., Pietrogrande, L., Biffi, A., Zuin, M., & Podda, M. (1994) · Hepatology · doi:10.1002/hep.1840200313 · Cited by 73
“The reported similarities in histologic features and high bone turnover in postmenopausal and PBC-associated osteoporosis (7, 8) constitute a rationale for testing calcitonin in clinical studies on the PBC-associated form of metabolic bone disease.”
BackgroundResultInfluentialOsteoporosis in liver diseases and after liver transplantation
Hay, J. E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00143-0 · Cited by 72
“The studies failing to show increased osteopenia in PBC generally have patients with earlier disease ([22], #317, [46], #44) or small numbers ([47], #43).”
BackgroundGuañabens, N., & Parés, A. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.030 · Cited by 71
Lithocholic acid downregulates vitamin D effects in human osteoblasts
Ruiz‐Gaspà, S., Guañabens, N., Enjuanes, A., Peris, P., Martinez‐Ferrer, A., Martinez de Osaba, M. J., Gonzalez, B., Alvarez, L., Monegal, A., Combalia, A., et al. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02230.x · Cited by 70
Parés, A. (2001) · Hepatology · doi:10.1053/jhep.2001.22758 · Cited by 69
Riemens, S. C., Oostdijk, A. H. J., van Doormaal, J. J., Thijn, C. J. P., Drent, G., Piers, D. A., Groen, E. W. J., Meerman, L., Slooff, M. J. H., & Haagsma, E. B. (1996) · Osteoporosis International · doi:10.1007/bf01622737 · Cited by 68
“After liver transplantation bone mass rapidly declines, despite preventive use of calcium and vitamin D supplements, leading to vertebral compression fractures in one third of patients, mainly in the first post-transplantation year [8-11].”
BackgroundResultEvidence of continuing bone recovery at a mean of 7 years after liver transplantation
Feller, R. B., McDonald, J. A., Sherbon, K. J., & McCaughan, G. W. (1999) · Liver Transplantation and Surgery · doi:10.1002/lt.500050507 · Cited by 69
Reduction of Bone Mass in Women after Bone Marrow Transplantation
Castañeda, S., Carmona, L., Carvajal, I., Arranz, R., Díaz, A., & García-Vadillo, A. (1997) · Calcified Tissue International · doi:10.1007/s002239900240 · Cited by 67
Pulmonary Complications of Orthotopic Liver Transplantation
Afessa, B., Gay, P. C., Plevak, D. J., Swensen, S. J., Patel, H. G., & Krowka, M. J. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60187-6 · Cited by 67
Influence of Age and Gender Before and After Liver Transplantation
Burra, P., Martin, E. D., Gitto, S., & Villa, E. (2012) · Liver Transplantation · doi:10.1002/lt.23574 · Cited by 72
Bone Disorders in Chronic Liver Diseases
Luxon, B. A. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0166-4 · Cited by 73
“Calcium A Eastell et al. [ 25 ], Epstein et al. [54]”
BackgroundOsteoporosis in primary biliary cirrhosis: pathogenesis and treatment
Parés, A., & Guañabens, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.02.005 · Cited by 63
Evaluation and Management of Osteoporosis in Liver Disease
Hay, J. E., & Guichelaar, M. M. J. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.07.003 · Cited by 66
“In ambulatory patients who had PBC [56], the z score of lumbar BMD correlated inversely with the bilirubin level.”
BackgroundOrmarsdóttir, S., Ljunggren, Ö., Mallmin, H., Brahm, H., & Lööf, L. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80167-6 · Cited by 71
Hay, J. E., Malinchoc, M., & Dickson, E. R. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00093-3 · Cited by 63
“In patients with primary biliary cirrhosis (PBC), the mean bone mineral density (BMD) of the lumbar spine is signi®cantly reduced, a reduction correlating with disease severity [6] and due to an increased rate of bone loss.”
BackgroundResultEarly increase in plama parathyroid hormone levels following liver transplantation
Compston, J. E., Greer, S., Skingle, S. J., Stirling, D. M., Price, C. P., Friend, P. J., & Alexander, G. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80243-1 · Cited by 59
Predicting bone loss following orthotopic liver transplantation
Crosbie, O. M., Freaney, R., McKenna, M. J., Curry, M. P., & Hegarty, J. E. (1999) · Gut · doi:10.1136/gut.44.3.430 · Cited by 58
“Further bone loss occurs in the first few months following orthotopic liver transplantation (OLT) and results in fracture rates of 17–65% in patients in the first year following OLT.”
BackgroundDodidou, P., Bruckner, T., Hosch, S., Haass, M., Klar, E., Sauer, P., Ziegler, R., & Leidig-Bruckner, G. (2003) · Osteoporosis International · doi:10.1007/s00198-002-1315-x · Cited by 57
“Furthermore, the decreasing femoral neck BMD values support the need for osteoporosis treatment also for those patients in whom treatment was not started immediately after transplantation, which is, of course, the time interval with the highest rates of bone loss and fracture risk [10,11,13].”
BackgroundEffects of orthotopic liver transplantation on body composition
Hussaini, S. H., Oldroyd, B., Stewart, S. P., Soo, S., Roman, F., Smith, M. A., Pollard, S., Lodge, P., O'Grady, J. G., & Losowsky, M. S. (1998) · Liver · doi:10.1111/j.1600-0676.1998.tb00146.x · Cited by 57
Bone Health in Patients With Liver Diseases
Danford, C. J., Trivedi, H. D., & Bonder, A. (2019) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2019.01.004 · Cited by 70
Floreani, A., Zappala, F., Fries, W., Naccarato, R., Plebani, M., D'Angelo, A., & Chiaramonte, M. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199706000-00012 · Cited by 57
Guo, G., Shi, Y., Wang, L., Ren, X., Han, Z., Guo, C., Cui, L.-N., Wang, J.-B., Zhu, J., Wang, N., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13244 · Cited by 67
Nakanuma, Y., Zen, Y., & Portmann, B. C. (2012) · MacSween's Pathology of the Liver · doi:10.1016/b978-0-7020-3398-8.00010-6 · Cited by 56
Monegal, A., Guañabens, N., Suárez, M. J., Suárez, F., Clemente, G., García-González, M., De la Mata, M., Serrano, T., Casafont, F., Torne, S., et al. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00763.x · Cited by 55
Boone, R. H., Cheung, A. M., Girlan, L. M., & Heathcote, E. J. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-8015-x · Cited by 54
“Rates of bone loss among patients with PBC are twice that of age- and sex-matched controls (1), and prevalence rates for osteoporosis among patients with PBC are 24–32% (2).”
BackgroundOrmarsdóttir, S., Mallmin, H., Naessén, T., Petrén‐Mallmin, M., Broomé, U., Hultcrantz, R., & Lööf, L. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01342.x · Cited by 55
Management of liver cirrhosis between primary care and specialists
Grattagliano, I., Ubaldi, E., Bonfrate, L., & Portincasa, P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2273 · Cited by 76
Bone Density in Heart or Lung Transplant Recipients-A Longitudinal Study
Wang, T. K. M., O’Sullivan, S., Gamble, G. D., & Ruygrok, P. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.09.117 · Cited by 53
Keogh, J. B., Tsalamandris, C., Sewell, R. B., Jones, R. M., Angus, P., Nyulasi, I. B., & Seeman, E. (1999) · Nutrition · doi:10.1016/s0899-9007(99)00121-5 · Cited by 51
Treatment of bone disorders in liver disease
Parés, A., & Guañabens, N. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.007 · Cited by 50
“Overall, approximately 23% of the patientswith liver disease have osteoporosis, with ahigher prevalence in patients with primary biliary cirrhosis (about 32%), since they have two additional risk factors: chronic cholestasis and female gender [8,9,15,18–23].”
BackgroundSafety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis
Menon, K. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00005-4 · Cited by 50
“One third of patients with PBC have osteoporosis at the time of diagnosis of their liver disease (1) and, in addition, the rate of bone loss in these patients is twice that of normal controls (2).”
BackgroundBone mineral density in long-term survivors following pediatric liver transplantation
Guthery, S. L., Pohl, J. F., Bucuvalas, J. C., Alonso, M. H., Ryckman, F. C., Balistreri, W. F., & Heubi, J. E. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50071 · Cited by 50
Pereira, S. P., O'Donohue, J., Moniz, C., Phillips, M. G., Abraha, H., Buxton‐Thomas, M., & Williams, R. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01890.x · Cited by 49
Atamaz, F., Hepguler, S., Akyildiz, M., Karasu, Z., & Kilic, M. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0082-5 · Cited by 46
“Ege Universite si Týp Fakultesi Fiziksel Týp ve Rehabilitasyon Anabilim Dalý, Bornova-Izmir, Turkey e-mail: atamaz_02@yahoo.com Tel.: +90-232-3904305 Fax: +90-232-3881953 Most patients are affected by osteoporosis, particularly within the first 3–6 months [1, 8–10], and the prevalence of fracture can be as high as 65%…”
Background
Metadata
- Authors
- Eastell, R., Dickson, R. E., Hodgson, S. F., Wiesner, R. H., Porayko, M. K., Wahner, H. W., Cedel, S. L., Riggs, L. B., & Krom, R. A. F.
- Affiliations
- Mayo Clinic (US)
- Venue
- Hepatology
- Published
- 1991-08
- Volume
- 14
- Issue
- 2
- Pages
- 296-300
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1982221537
- Cited by
- 297
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 8797 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01am033230-02)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- primary biliary cirrhosis, osteoporosis, bone mineral density, vertebral bone loss, liver transplantation, atraumatic fractures, lumbar spine, women, liver disease severity
- MeSH terms
- Female, Humans, Liver Cirrhosis, Biliary, Middle Aged, Osteoporosis, Postoperative Period, Spinal Diseases, Absorptiometry, Photon, Liver Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.